Breaking News

Dalton, Cerium Ink Development & Mfg. Agreement

Will provide formulation development, liquid filling, analytical method validation, QC testing and ICH stability services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dalton Pharma Services has entered a drug development and manufacturing services agreement with Cerium Pharmaceuticals, Inc., an emerging biopharma company focused on rare diseases based in Gaithersburg, MD.   Dalton will provide formulation development, cGMP liquid filling, analytical method validation, quality control release testing and ICH stability services to support of Cerium’s drug development program.   “Our expert capabilities in formulation development and sterile fill/finis...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters